Fibrin-incorporated vitronectin is involved in platelet adhesion and thrombus formation through homotypic interactions with platelet-associated vitronectin.

When a blood clot is formed, vitronectin (VN) is incorporated. Here we studied the consequence of VN incorporation for platelet interactions under flow. Perfusion of whole blood over a fibrin network, formed from purified fibrinogen, resulted in approximately 20% surface coverage with blood platelets. Incorporation of purified multimeric VN into the fibrin network resulted in a 2-fold increase in surface coverage with platelets and in enhancement of platelet aggregate formation. A human monoclonal antibody (huMab VN18), directed against the multimeric form of VN, inhibited platelet adhesion to the combined fibrin/VN matrix to the level of adhesion on fibrin alone. This inhibition was also shown when whole blood was perfused over a plasma-derived clot. Surprisingly, the inhibitory action of the antibody was not directed toward VN incorporated into the fibrin network but toward VN released from the platelets. We conclude that VN-potentiated platelet-clot interaction requires VN in the clot and multimeric VN bound to the platelet surface. Our results provide evidence that homotypic VN interactions contribute to platelet adhesion and aggregation to a blood clot. This report demonstrates for the first time that self-assembly of VN may provide a physiologically relevant contribution to platelet aggregation on a blood clot.

[1]  W. Landman,et al.  Activated vitronectin as a target for anticancer therapy with human antibodies , 2004, Cancer Immunology, Immunotherapy.

[2]  D. Loskutoff,et al.  Do PAI-1 and vitronectin promote or inhibit neointima formation? The exact role of the fibrinolytic system in vascular remodeling remains uncertain. , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[3]  R. Colman,et al.  Inhibition of Platelet Adhesion and Aggregation by a Defined Region (Gly-486–Lys-502) of High Molecular Weight Kininogen* , 2002, The Journal of Biological Chemistry.

[4]  R. Jordan,et al.  An Additional Mechanism of Action of Abciximab: Dispersal of Newly Formed Platelet Aggregates , 2002, Thrombosis and Haemostasis.

[5]  S. Futaki,et al.  Kinetic Analysis of the Interaction between Vitronectin and the Urokinase Receptor* , 2002, The Journal of Biological Chemistry.

[6]  T. Podor,et al.  Incorporation of Vitronectin into Fibrin Clots , 2002, The Journal of Biological Chemistry.

[7]  S. Shaltiel,et al.  Truncated vitronectins: binding to immobilized fibrin and to fibrin clots, and their subsequent interaction with cells. , 2002, Biochemical and biophysical research communications.

[8]  J. Sixma,et al.  Functional self-association of von Willebrand factor during platelet adhesion under flow , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[9]  D. Loskutoff,et al.  Plasminogen Activator Inhibitor-1 and Its Cofactor Vitronectin Stabilize Arterial Thrombi After Vascular Injury in Mice , 2001, Circulation.

[10]  Thomas N. Sato,et al.  Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen. , 2000, The Journal of clinical investigation.

[11]  D. Lawrence,et al.  Type 1 Plasminogen Activator Inhibitor Binds to Fibrin via Vitronectin* , 2000, The Journal of Biological Chemistry.

[12]  J. Sixma,et al.  Platelet thrombus formation on collagen at high shear rates is mediated by von Willebrand factor-glycoprotein Ib interaction and inhibited by von Willebrand factor-glycoprotein IIb/IIIa interaction. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[13]  J. Soria,et al.  Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: dynamic and structural approaches by confocal microscopy. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[14]  E. Nabel,et al.  Plasminogen activator inhibitor-1 and vitronectin promote vascular thrombosis in mice. , 2000, Blood.

[15]  W. Fay,et al.  Vitronectin inhibits the thrombotic response to arterial injury in mice. , 1999, Blood.

[16]  K. Preissner,et al.  The role of plasminogen activator inhibitor‐1 as inhibitor of platelet and megakaryoblastic cell adhesion , 1999, British journal of haematology.

[17]  D. Seiffert,et al.  Two functionally distinct pools of vitronectin (Vn) in the blood circulation: identification of a heparin-binding competent population of Vn within platelet alpha-granules. , 1996, Blood.

[18]  D. Loskutoff,et al.  Structural and Functional Analysis of the Plasminogen Activator Inhibitor-1 Binding Motif in the Somatomedin B Domain of Vitronectin* , 1996, The Journal of Biological Chemistry.

[19]  J. Sixma,et al.  Platelet adhesion to multimeric and dimeric von Willebrand factor and to collagen type III preincubated with von Willebrand factor. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[20]  J. Sixma,et al.  Role of the glycoprotein Ib-binding A1 repeat and the RGD sequence in platelet adhesion to human recombinant von Willebrand factor. , 1995, Blood.

[21]  J. Sixma,et al.  Evidence that fibrin alpha-chain RGDX sequences are not required for platelet adhesion in flowing whole blood. , 1995, Blood.

[22]  K. Preissner,et al.  The Versatility of Adhesion Receptor Ligands in Haemostasis: Morpho-Regulatory Functions of Vitronectin , 1995, Thrombosis and Haemostasis.

[23]  O. Sigurdardottir,et al.  Identification of a PAI-1 binding site in vitronectin. , 1994, Biochimica et biophysica acta.

[24]  J. Sixma,et al.  Platelet adhesion to collagen types I through VIII under conditions of stasis and flow is mediated by GPIa/IIa (alpha 2 beta 1-integrin). , 1994, Blood.

[25]  B. Binder,et al.  The somatomedin B domain of vitronectin. Structural requirements for the binding and stabilization of active type 1 plasminogen activator inhibitor. , 1994, The Journal of biological chemistry.

[26]  R. Timpl,et al.  Multimeric vitronectin. Identification and characterization of conformation-dependent self-association of the adhesive protein. , 1993, The Journal of biological chemistry.

[27]  P. Thiagarajan,et al.  Site-directed mutagenesis of the arginine-glycine-aspartic acid in vitronectin abolishes cell adhesion. , 1993, The Journal of biological chemistry.

[28]  A. Wittwer,et al.  Cross-competition for binding of alpha 1-antitrypsin (alpha 1 AT)-elastase complexes to the serpin-enzyme complex receptor by other serpin-enzyme complexes and by proteolytically modified alpha 1 AT. , 1993, The Journal of biological chemistry.

[29]  K. Preissner,et al.  Ternary vitronectin-thrombin-antithrombin III complexes in human plasma. Detection and mode of association. , 1993, The Journal of biological chemistry.

[30]  T. K. Gartner,et al.  A peptide corresponding to GPIIb alpha 300-312, a presumptive fibrinogen gamma-chain binding site on the platelet integrin GPIIb/IIIa, inhibits the adhesion of platelets to at least four adhesive ligands. , 1992, The Journal of biological chemistry.

[31]  B. Coller,et al.  Platelet fibrinogen and vitronectin in Glanzmann thrombasthenia: evidence consistent with specific roles for glycoprotein IIb/IIIA and alpha v beta 3 integrins in platelet protein trafficking [see comments] , 1991 .

[32]  D. Loskutoff,et al.  Evidence that type 1 plasminogen activator inhibitor binds to the somatomedin B domain of vitronectin. , 1991, The Journal of biological chemistry.

[33]  E. Podack,et al.  Vitronectin binds to activated human platelets and plays a role in platelet aggregation. , 1990, The Journal of clinical investigation.

[34]  K. Preissner,et al.  Identification of and partial characterization of platelet vitronectin: evidence for complex formation with platelet-derived plasminogen activator inhibitor-1. , 1989, Blood.

[35]  C. Parker,et al.  Vitronectin (S protein) is associated with platelets , 1989, British journal of haematology.

[36]  M. Hayashi,et al.  Novel purification of vitronectin from human plasma by heparin affinity chromatography. , 1988, Cell structure and function.

[37]  P. Thiagarajan,et al.  Exposure of binding sites for vitronectin on platelets following stimulation. , 1988, The Journal of biological chemistry.

[38]  P. Lansdorp,et al.  Monoclonal antibodies against human platelet glycoprotein IIIa , 1983, British journal of haematology.

[39]  T. Podor,et al.  Incorporation of vitronectin into fibrin clots. Evidence for a binding interaction between vitronectin and gamma A/gamma' fibrinogen. , 2002, The Journal of biological chemistry.

[40]  K. Preissner,et al.  Localization of protein kinase A and vitronectin in resting platelets and their translocation onto fibrin fibers during clot formation. , 2001, European journal of cell biology.

[41]  B. Coller,et al.  Platelet fibrinogen and vitronectin in Glanzmann thrombasthenia: evidence consistent with specific roles for glycoprotein IIb/IIIA and alpha v beta 3 integrins in platelet protein trafficking. , 1991, Blood.